An ethical case concerns a 16-year-old girl suffering from systemic scleroderma with a poor prognosis and her father's cultural beliefs, which do not allow for discussions about end-of-life care.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.